AJMC September 16, 2024
A biosimilar is a biologic medication that is highly similar to an existing FDA-approved biologic, known as a reference product, with no clinically meaningful differences. Biosimilars are derived from the same types of living sources, administered in the same way, and have the same strength, dosage, therapeutic benefits, and adverse events as the reference product. They can be used in both treatment-experienced patients and those who are treatment naive. As patent protections for many reference biologics expire, biosimilars are expanding as viable alternatives, with the potential to enhance patient access to essential therapies and drive competition within the market. Current prescribing trends indicate a growing acceptance and integration of biosimilars as part of prescribing practices and treatment protocols by health...
Today's Sponsors
Today's Sponsor